Statistical analysis showed that HSP90α was at significantly higher levels in HH, SHC and HCC patient cohorts when compared to the HD cohort (p < 0.001, p < 0.001, p < 0.001, respectively). The gene discussed is HSP90AA1; the disease is hepatocellular carcinoma.